ECONOPRED Drug Patent Profile
✉ Email this page to a colleague
When do Econopred patents expire, and what generic alternatives are available?
Econopred is a drug marketed by Harrow Eye and is included in one NDA.
The generic ingredient in ECONOPRED is prednisolone acetate. There are eighty-eight drug master file entries for this compound. Seven suppliers are listed for this compound. Additional details are available on the prednisolone acetate profile page.
AI Research Assistant
Questions you can ask:
- What is the 5 year forecast for ECONOPRED?
- What are the global sales for ECONOPRED?
- What is Average Wholesale Price for ECONOPRED?
Summary for ECONOPRED
US Patents: | 0 |
Applicants: | 1 |
NDAs: | 1 |
Raw Ingredient (Bulk) Api Vendors: | 74 |
Clinical Trials: | 3 |
Patent Applications: | 3,815 |
Formulation / Manufacturing: | see details |
DailyMed Link: | ECONOPRED at DailyMed |
![ECONOPRED drug patent expirations Drug patent expirations by year for ECONOPRED](/p/graph/s/t/ECONOPRED-patent-expirations.png)
Recent Clinical Trials for ECONOPRED
Identify potential brand extensions & 505(b)(2) entrants
Sponsor | Phase |
---|---|
University of California, San Francisco | Phase 4 |
Winston Chamberlain, MD, PhD | Phase 4 |
Stanford University | Phase 4 |
US Patents and Regulatory Information for ECONOPRED
Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | TE | Type | RLD | RS | Patent No. | Patent Expiration | Product | Substance | Delist Req. | Exclusivity Expiration |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Harrow Eye | ECONOPRED | prednisolone acetate | SUSPENSION/DROPS;OPHTHALMIC | 017468-001 | Approved Prior to Jan 1, 1982 | DISCN | No | No | ⤷ Sign Up | ⤷ Sign Up | ⤷ Sign Up | ||||
>Applicant | >Tradename | >Generic Name | >Dosage | >NDA | >Approval Date | >TE | >Type | >RLD | >RS | >Patent No. | >Patent Expiration | >Product | >Substance | >Delist Req. | >Exclusivity Expiration |